Data as of Dec 10
| +0.003 / +2.54%|
The 1 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 0.50, with a high estimate of 0.50 and a low estimate of 0.50. The median estimate represents a +313.22% increase from the last price of 0.12.
The current consensus among 1 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.